Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows (Unaudited)

v3.19.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Cash flows from operating activities:    
Net loss $ (2,548,875) $ (7,011,394)
Adjustments to reconcile net loss to net cash used in operating activities:    
Accrued (income)/loss on marketable securities 6,289 (10,633)
Depreciation and amortization 54,522 173,047
Reserve for obsolete inventory 126,422 218,799
Reserve for doubtful accounts 105,325 97,000
(Gain)/loss on sale of securities (2,155) 11,300
Amortization of deferred compensation 3,469
Share based compensation to an employees - options 6,931
Share based compensation to an employees - restricted stock 25,555 5,175
Share based compensation to directors - restricted stock units 242,165
Share based compensation to non-employees - restricted stock 12,545
Change in assets and liabilities    
(Increase)/decrease in trade receivables (59,899) 584,443
Decrease in deposits and other receivables 9,347 (44,079)
(Increase)/decrease in inventory 46,786 (79,162)
(Increase)/decrease in prepaid expenses 18,147 (347,154)
Decrease in other assets 4,330  
Increase/(decrease) in trade and other payables (600,537) 516,349
Net cash used by operating activities (2,572,578) (5,863,364)
Cash flows from investing activities:    
Purchases of plant, property & equipment (68,214)
Short-term note receivable (100,000)
Purchases of marketable securities (87,305) (5,321,298)
Proceeds from sale of marketable securities 2,556,516 5,460,662
Net cash provided/(used) by investing activities 2,369,211 71,150
Cash flows from financing activities    
Proceeds from exercise of warrants for common stock 7,155,200
Net cash provided by financing activities 7,155,200
Net increase/(decrease) in cash and restricted cash (203,367) 1,362,986
Cash and restricted cash at beginning of period 681,755 438,432
Cash and restricted cash at end of period 478,388 1,801,418
Cash paid for:    
Interest
Income Taxes
Supplemental Schedule of Non-Cash Financing and Investing Activities    
Net unrealized gains/(losses) on marketable securities 45,597 (5,543)
Conversion of Series B Preferred Shares to common shares $ 1,755,000